Panacea Biotec Limited
5,359words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
1 NSE Symbol: PANACEABIO BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349 Sub.: Iuvestor Presentation Dear Sir/Mada
73.59%
otechnology company, Listed on NSE and BSE the leading research-based Promoter & Promoter Group (73.59%) Public Shareholders (26.41%) 02 At the forefront in vaccine development with established brand
26.41%
NSE and BSE the leading research-based Promoter & Promoter Group (73.59%) Public Shareholders (26.41%) 02 At the forefront in vaccine development with established brand equity in India & internationa
₹20,562
ty and chronic care segments - Organ Transplantation, Oncology and Diabetes Market Capitalization ₹20,562 mn** Panacea Biotec Ltd. Vaccine Business 100% Panacea Biotec Pharma Ltd. Pharmaceutical Busin
100%
Oncology and Diabetes Market Capitalization ₹20,562 mn** Panacea Biotec Ltd. Vaccine Business 100% Panacea Biotec Pharma Ltd. Pharmaceutical Business FINANCIALS ₹ Mn S T H G I L H G I H &
15.1%
TDA* 1,404 2,278 4,037 3,970 5,441 6,248 (137) 113 909 690 772 803 EBITDA margin (%) (15.1%) 4.9% 22.5% 17.4% 14.2% 12.8% Total Assets# 7,386 7,531 3,587 4,257 13,903$ 11,788 Tot
4.9%
404 2,278 4,037 3,970 5,441 6,248 (137) 113 909 690 772 803 EBITDA margin (%) (15.1%) 4.9% 22.5% 17.4% 14.2% 12.8% Total Assets# 7,386 7,531 3,587 4,257 13,903$ 11,788 Total Liab
22.5%
,278 4,037 3,970 5,441 6,248 (137) 113 909 690 772 803 EBITDA margin (%) (15.1%) 4.9% 22.5% 17.4% 14.2% 12.8% Total Assets# 7,386 7,531 3,587 4,257 13,903$ 11,788 Total Liabilities
17.4%
,037 3,970 5,441 6,248 (137) 113 909 690 772 803 EBITDA margin (%) (15.1%) 4.9% 22.5% 17.4% 14.2% 12.8% Total Assets# 7,386 7,531 3,587 4,257 13,903$ 11,788 Total Liabilities exclu
14.2%
,970 5,441 6,248 (137) 113 909 690 772 803 EBITDA margin (%) (15.1%) 4.9% 22.5% 17.4% 14.2% 12.8% Total Assets# 7,386 7,531 3,587 4,257 13,903$ 11,788 Total Liabilities excluding Eq
12.8%
,441 6,248 (137) 113 909 690 772 803 EBITDA margin (%) (15.1%) 4.9% 22.5% 17.4% 14.2% 12.8% Total Assets# 7,386 7,531 3,587 4,257 13,903$ 11,788 Total Liabilities excluding Equity#
INR 180
accines 1989 : Established production facilities for pharmaceutical formulations 1995 : IPO of INR 180 mn 2003 : WHO pre-qualification for tetravalent vaccine (DTwP-HepB) and Oral Polio Vaccine 2005
Advertisement